Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims.
Internal Medicine, Cardiology, Critical Care
Vascular medicine (London, England)
Administrative Claims, Healthcare, Adult, Aged, Comparative Effectiveness Research, Databases, Factual, Female, Fibrinolytic Agents, Hemorrhage, Hospital Mortality, Humans, Male, Middle Aged, Pulmonary Embolism, Retrospective Studies, Risk Assessment, Risk Factors, Thrombolytic Therapy, Time Factors, Treatment Outcome, United States
Catheter-directed thrombolysis (CDT) and systemic thrombolysis (ST) are used to treat intermediate/high-risk pulmonary embolism (PE) in the absence of comparative safety and effectiveness data. We utilized a large administrative database to perform a comparative safety and effectiveness analysis of catheter-directed versus systemic thrombolysis. From the Optum
Geller, Bram J; Adusumalli, Srinath; Pugliese, Steven C; Khatana, Sameed Ahmed M; Nathan, Ashwin; Weinberg, Ido; Jaff, Michael R; Kobayashi, Taisei; Mazurek, Jeremy A; Khandhar, Sameer; Yang, Lin; Groeneveld, Peter W; and Giri, Jay S, "Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims." (2020). Maine Medical Center. 1910.